Masimo Current Ratio 2007-2019 | MASI
Current and historical current ratio for Masimo (MASI) from 2007 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Masimo current ratio for the three months ending March 31, 2019 was 7.02.
| Masimo Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2019-03-31 | $0.85B | $0.12B | 7.02 |
| 2018-12-31 | $0.79B | $0.15B | 5.33 |
| 2018-09-30 | $0.74B | $0.14B | 5.12 |
| 2018-06-30 | $0.65B | $0.13B | 5.05 |
| 2018-03-31 | $0.60B | $0.13B | 4.55 |
| 2017-12-31 | $0.56B | $0.13B | 4.32 |
| 2017-09-30 | $0.55B | $0.17B | 3.17 |
| 2017-06-30 | $0.57B | $0.15B | 3.89 |
| 2017-03-31 | $0.56B | $0.20B | 2.75 |
| 2016-12-31 | $0.51B | $0.22B | 2.30 |
| 2016-09-30 | $0.33B | $0.14B | 2.25 |
| 2016-06-30 | $0.30B | $0.12B | 2.46 |
| 2016-03-31 | $0.32B | $0.12B | 2.65 |
| 2015-12-31 | $0.30B | $0.13B | 2.26 |
| 2015-09-30 | $0.30B | $0.11B | 2.66 |
| 2015-06-30 | $0.31B | $0.11B | 2.71 |
| 2015-03-31 | $0.32B | $0.12B | 2.69 |
| 2014-12-31 | $0.30B | $0.12B | 2.40 |
| 2014-09-30 | $0.30B | $0.24B | 1.25 |
| 2014-06-30 | $0.27B | $0.17B | 1.59 |
| 2014-03-31 | $0.29B | $0.10B | 2.96 |
| 2013-12-31 | $0.27B | $0.10B | 2.62 |
| 2013-09-30 | $0.26B | $0.10B | 2.53 |
| 2013-06-30 | $0.24B | $0.09B | 2.54 |
| 2013-03-31 | $0.23B | $0.10B | 2.37 |
| 2012-12-31 | $0.22B | $0.09B | 2.45 |
| 2012-09-30 | $0.26B | $0.08B | 3.08 |
| 2012-06-30 | $0.27B | $0.08B | 3.55 |
| 2012-03-31 | $0.27B | $0.09B | 2.98 |
| 2011-12-31 | $0.26B | $0.08B | 3.46 |
| 2011-09-30 | $0.28B | $0.07B | 4.19 |
| 2011-06-30 | $0.25B | $0.06B | 4.08 |
| 2011-03-31 | $0.23B | $0.06B | 3.67 |
| 2010-12-31 | $0.22B | $0.07B | 3.10 |
| 2010-09-30 | $0.25B | $0.07B | 3.55 |
| 2010-06-30 | $0.23B | $0.06B | 3.54 |
| 2010-03-31 | $0.22B | $0.07B | 3.01 |
| 2009-12-31 | $0.29B | $0.06B | 4.87 |
| 2009-09-30 | $0.28B | $0.06B | 4.87 |
| 2009-06-30 | $0.25B | $0.05B | 4.75 |
| 2009-03-31 | $0.24B | $0.06B | 4.02 |
| 2008-12-31 | $0.23B | $0.07B | 3.54 |
| 2008-09-30 | $0.22B | $0.05B | 4.06 |
| 2008-06-30 | $0.20B | $0.06B | 3.39 |
| 2008-03-31 | $0.17B | $0.06B | 3.18 |
| 2007-12-31 | $0.18B | $0.06B | 2.97 |
| 2007-09-30 | $0.18B | $0.06B | 2.77 |
| 2007-06-30 | $0.12B | $0.07B | 1.78 |
| 2007-03-31 | $0.00B | $0.00B | 0.00 |
| 2006-09-30 | $0.00B | $0.00B | 0.00 |
| 2006-06-30 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.387B | $0.858B |
| Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $105.159B | 23.00 |
| Intuitive Surgical (ISRG) | United States | $55.787B | 51.41 |
| Edwards Lifesciences (EW) | United States | $36.025B | 36.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $23.498B | 15.44 |
| IDEXX Laboratories (IDXX) | United States | $21.386B | 56.10 |
| Teleflex (TFX) | United States | $13.465B | 29.17 |
| Hologic (HOLX) | United States | $12.009B | 19.31 |
| Varian Medical Systems (VAR) | United States | $11.869B | 30.28 |
| STERIS (STE) | United Kingdom | $11.399B | 27.56 |
| ABIOMED (ABMD) | United States | $11.388B | 69.58 |
| DexCom (DXCM) | United States | $10.787B | 211.55 |
| Penumbra (PEN) | United States | $4.830B | 204.49 |
| Integra LifeSciences Holdings (IART) | United States | $4.229B | 19.87 |
| Globus Medical (GMED) | United States | $4.125B | 25.72 |
| Wright Medical Group (WMGI) | Netherlands | $3.961B | 785.25 |
| Tandem Diabetes Care (TNDM) | United States | $3.853B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.556B | 23.18 |
| Cantel Medical (CMD) | United States | $2.781B | 27.66 |
| Glaukos (GKOS) | United States | $2.415B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.251B | 16.59 |
| AVANOS MEDICAL, INC (AVNS) | United States | $2.020B | 31.97 |
| Nevro (NVRO) | United States | $1.833B | 0.00 |
| ShockWave Medical (SWAV) | United States | $1.625B | 0.00 |
| Inogen (INGN) | United States | $1.534B | 33.96 |
| Silk Road Medical (SILK) | United States | $1.427B | 0.00 |
| OPKO Health (OPK) | United States | $1.225B | 0.00 |
| CryoLife (CRY) | United States | $1.095B | 108.59 |
| Pacific Biosciences Of California (PACB) | United States | $1.082B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $1.035B | 0.00 |
| Veracyte (VCYT) | United States | $1.007B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.988B | 28.64 |
| Mesa Laboratories (MLAB) | United States | $0.957B | 39.15 |
| Tactile Systems Technology (TCMD) | United States | $0.934B | 137.81 |
| Luminex (LMNX) | United States | $0.934B | 122.12 |
| Natus Medical (BABY) | United States | $0.893B | 20.67 |
| ViewRay (VRAY) | United States | $0.840B | 0.00 |
| Fluidigm (FLDM) | United States | $0.838B | 0.00 |
| Intersect ENT (XENT) | United States | $0.804B | 0.00 |
| AxoGen (AXGN) | United States | $0.799B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.719B | 25.09 |
| Quotient (QTNT) | Switzerland | $0.597B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.593B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.552B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.405B | 21.71 |
| Si-Bone (SIBN) | United States | $0.397B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.392B | 0.00 |
| Accuray (ARAY) | United States | $0.341B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.325B | 40.00 |
| TransEnterix (TRXC) | United States | $0.280B | 0.00 |
| Neuronetics (STIM) | United States | $0.269B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.269B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.258B | 0.00 |
| IRadimed (IRMD) | United States | $0.235B | 44.89 |
| ConforMIS (CFMS) | United States | $0.233B | 0.00 |
| Sientra (SIEN) | United States | $0.207B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.206B | 72.00 |
| Alphatec Holdings (ATEC) | United States | $0.198B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.151B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.123B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.111B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.106B | 0.00 |
| EDAP TMS (EDAP) | France | $0.101B | 0.00 |
| Vermillion (VRML) | United States | $0.094B | 0.00 |
| Soliton (SOLY) | $0.094B | 0.00 | |
| Sensus Healthcare (SRTS) | United States | $0.089B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.079B | 0.00 |
| Nuvectra (NVTR) | United States | $0.079B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.067B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.062B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.058B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.055B | 0.00 |
| Electromed (ELMD) | United States | $0.047B | 24.26 |
| Xtant Medical Holdings (XTNT) | United States | $0.040B | 0.00 |
| PAVmed (PAVM) | United States | $0.034B | 0.00 |
| Avinger (AVGR) | United States | $0.032B | 0.00 |
| Neovasc (NVCN) | Canada | $0.032B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.031B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.028B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.026B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.023B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.023B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.020B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.016B | 17.94 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.014B | 0.00 |
| Dynatronics (DYNT) | United States | $0.014B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.012B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.012B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.009B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.008B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.008B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| InspireMD (NSPR) | Israel | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
| ALCON INC (ALC) | $0.000B | 0.00 |
